Hepatitis B is a viral disease affecting the liver, spread by contaminated blood and body products. It occurs world wide.
Travellers can be exposed from:
Symptoms more commonly occur in adults than children and may include: jaundice , loss of appetite, fever and abdominal pain. Persistent hepatitis B infection develops in 80 to 90 percent of those infected in the first year of life and in only five percent of those infected in adult years. Persistent infection may lead to liver failure or liver cancer.
Recommended for all travellers at risk.
Standard schedule : 0,1,6 months.
Rapid schedule : 0,1,2 months and booster at 12 months.
Very rapid schedule : 0,7,21 days and booster at 12 months ( over 18 years only)
Injection site reaction
Headache, fever, general malaise, nausea.
Registered in England & Wales. Company Number: 9474519. Registered Office: 45 South Street, Dorking, Surrey, RH4 2JX.